LipoScience
HPLC assay for urinary albumin was analytically validated in diabetic and nondiabetics
Published in Health Business Week, June 30th, 2006
According to recent research from the United States, "Microalbuminuria is the earliest clinical finding for renal disease. Diabetic individuals often produce modified forms of albumin, perhaps due to impaired lysosomal processing, that are undetectable by common immunoassays but accurately measured by HPLC. We evaluated the performance of a commercially available, FDA-approved HPLC assay (AusAm Biotechnologies, NY) and compare results to our immunoturbidimetric assay (ITA, Beckman-Coulter, CA) using random urine specimens from 32 nondiabetic and 60 type 1 and 2 diabetic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-06-30)
More Articles from Health Business Week
- Ascentia Biomedical Corp.
Ascentia Biomedical shifts to biomedical arbitrage, development to achieve profitability - BioMS Medical Corp.
BioMS Medical sells units in private placement valued at $15M - BioSyntech, Inc.
BioSyntech appoints new board member - Bioject Medical Technologies, Inc.
Bioject completes financing and signs agreement - Biovail Corp.
Biovail commences offer to purchase $56.6M of its subordinated notes - CV Therapeutics, Inc.
CV Therapeutics reports option grants under Nasdaq Marketplace Rule 4350 - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
